Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 195

1.

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach.

Kramer RM, Archer MC, Orr MT, Dubois Cauwelaert N, Beebe EA, Huang PD, Dowling QM, Schwartz AM, Fedor DM, Vedvick TS, Fox CB.

Int J Nanomedicine. 2018 Jun 26;13:3689-3711. doi: 10.2147/IJN.S159839. eCollection 2018.

2.

The Value of Using Multiple Metrics to Evaluate PCB Exposure.

Archer MC, Harwood AD, Nutile SA, Hartz KEH, Mills MA, Garvey JE, Lydy MJ.

Arch Environ Contam Toxicol. 2018 Apr;74(3):361-371. doi: 10.1007/s00244-017-0418-5. Epub 2017 Jun 10.

PMID:
28601932
3.

Lyophilization of an Adjuvanted Mycobacterium tuberculosis Vaccine in a Single-Chamber Pharmaceutical Cartridge.

Barnes V L, Fedor DM, Williams S, Dowling QM, Archer MC, Cloutier S, Parker S, Vedvick TS, Fox CB, Kramer RM.

AAPS PharmSciTech. 2017 Aug;18(6):2077-2084. doi: 10.1208/s12249-016-0688-7. Epub 2016 Dec 20.

PMID:
28000085
4.

The interplay between cell signalling and the mevalonate pathway in cancer.

Mullen PJ, Yu R, Longo J, Archer MC, Penn LZ.

Nat Rev Cancer. 2016 Nov;16(11):718-731. doi: 10.1038/nrc.2016.76. Epub 2016 Aug 26. Review.

PMID:
27562463
5.

Risk factors for colorectal cancer in man induce aberrant crypt foci in rats: Preliminary findings.

Yang K, Fard S, Furrer R, Archer MC, Bruce WR, Lip H, Mehta R, O'Brien PJ, Giacca A, Ward WE, Femia AP, Caderni G, Medline A, Banks K.

Nutr Cancer. 2016;68(1):94-104. doi: 10.1080/01635581.2016.1115098. Epub 2015 Dec 28.

6.

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.

Menezes ME, Shen XN, Das SK, Emdad L, Guo C, Yuan F, Li YJ, Archer MC, Zacksenhaus E, Windle JJ, Subler MA, Ben-David Y, Sarkar D, Wang XY, Fisher PB.

Oncotarget. 2015 Nov 10;6(35):36928-42. doi: 10.18632/oncotarget.6047.

7.

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.

Li YJ, Liu G, Xia L, Xiao X, Liu JC, Menezes ME, Das SK, Emdad L, Sarkar D, Fisher PB, Archer MC, Zacksenhaus E, Ben-David Y.

Oncotarget. 2015 Nov 10;6(35):36943-54. doi: 10.18632/oncotarget.6046.

8.

Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity.

Hopperton KE, Duncan RE, Bazinet RP, Archer MC.

Exp Cell Res. 2014 Jan 15;320(2):302-10. doi: 10.1016/j.yexcr.2013.10.016. Epub 2013 Nov 4.

PMID:
24200503
9.

mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of β1 integrin function.

Li YJ, Liu G, Li Y, Vecchiarelli-Federico LM, Liu JC, Zacksenhaus E, Shan SW, Yang BB, Li Q, Dash R, Fisher PB, Archer MC, Ben-David Y.

Mol Cancer Res. 2013 Jun;11(6):593-603. doi: 10.1158/1541-7786.MCR-12-0496. Epub 2013 Mar 6.

10.

Role of sp transcription factors in the regulation of cancer cell metabolism.

Archer MC.

Genes Cancer. 2011 Jul;2(7):712-9. doi: 10.1177/1947601911423029.

11.

Inhibition of fatty acid synthase and Sp1 expression by 3,3'-diindolylmethane in human breast cancer cells.

Saati GE, Archer MC.

Nutr Cancer. 2011;63(5):790-4. doi: 10.1080/01635581.2011.570896. Epub 2011 Jun 22.

PMID:
21767081
12.

The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum.

Esfahani A, Kendall CW, Bashyam B, Archer MC, Jenkins DJ.

In Vitro Cell Dev Biol Anim. 2010 Dec;46(10):856-62. doi: 10.1007/s11626-010-9351-x. Epub 2010 Oct 7.

PMID:
20927603
13.

Diabetes and cancer: a consensus report.

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D.

Diabetes Care. 2010 Jul;33(7):1674-85. doi: 10.2337/dc10-0666.

14.

Diabetes and cancer: a consensus report.

Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D.

CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. doi: 10.3322/caac.20078. Epub 2010 Jun 16.

15.
16.

Ezetimibe reverses the inhibitory effects of dietary cholesterol on mammary tumorigenesis in rats.

McNamara E, Archer MC.

Int J Cancer. 2010 Aug 15;127(4):791-5. doi: 10.1002/ijc.25089.

17.

Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.

Lu S, Archer MC.

Int J Cancer. 2010 Jan 15;126(2):416-25. doi: 10.1002/ijc.24761.

18.

Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.

Xuan W, Li YJ, Liu G, Ben-David Y, Archer MC.

Mol Cancer Res. 2009 Mar;7(3):433-42. doi: 10.1158/1541-7786.MCR-08-0252. Epub 2009 Mar 3.

19.

Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane.

Lau DS, Archer MC.

Int J Cancer. 2009 Jun 1;124(11):2750-3. doi: 10.1002/ijc.24242.

Supplemental Content

Loading ...
Support Center